Cargando…

Clinical Evaluation of Two Non-Invasive Genetic Tests for Detection and Monitoring of Urothelial Carcinoma: Validation of UroVysion and Xpert Bladder Cancer Detection Test

A variety of commercially available urinary molecular markers have been introduced for detecting and monitoring urothelial carcinoma (UC). We prospectively evaluated the UroVysion(TM) Bladder Cancer Kit (FISH) and the Xpert® Bladder Cancer Detection (Xpert) test. Both tests were performed on voided...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kavcic, Niko, Peric, Ivan, Zagorac, Andreja, Kokalj Vokac, Nadja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208547/ https://www.ncbi.nlm.nih.gov/pubmed/35734425 http://dx.doi.org/10.3389/fgene.2022.839598

Ejemplares similares

Evaluation of UroVysion for Urachal Carcinoma Detection
por: Hu, Zhiquan, et al.
Publicado: (2020)

UroVysion fluorescence in situ hybridization (UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary study
por: Dodurga, Yavuz, et al.
Publicado: (2013)

A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection
por: Lavery, Hugh J., et al.
Publicado: (2017)

Refined pancreatobiliary UroVysion criteria and an approach for further optimization
por: Mettman, Daniel, et al.
Publicado: (2021)

UroVysion fluorescence in situ hybridization in urothelial carcinoma: a narrative review and future perspectives
por: Nagai, Takashi, et al.
Publicado: (2021)

AB051. Comparison of urine cytology and UroVysion FISH for upper tract urothelial carcinoma detection in Chinese patients
por: Peng, Weibin, et al.
Publicado: (2016)

Performance of the UroVysion (®) FISH assay for the diagnosis of malignant effusions using two cutoff strategies
por: Rosolen, Débora C. B., et al.
Publicado: (2018)

UroVysion(™) fluorescence in situ hybridization (FISH) possibly has a high positive rate in carcinoma of non-urothelial lineages
por: Ke, Chunjin, et al.
Publicado: (2023)

A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVysion® FISH, NMP22® and cytology based on imputation of multiple datasets
por: Breen, Vivienne, et al.
Publicado: (2015)

Can Reflex UroVysion fluorescence in situ hybridization predict tumor recurrence during follow-up?
por: Kurien, Annamma, et al.
Publicado: (2007)

UroVysion(TM) Fluorescence In Situ Hybridization in Urological Cancers: A Narrative Review and Future Perspectives
por: Ke, Chunjin, et al.
Publicado: (2022)

Examination of Diagnostic Accuracy of UroVysion Fluorescence In Situ Hybridization for Bladder Cancer in a Single Community of Japanese Hospital Patients
por: Nagai, Takashi, et al.
Publicado: (2019)

Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan
por: Ikeda, Atsushi, et al.
Publicado: (2020)

Comparative study of ProEx C immunocytochemistry and UroVysion fluorescent in-situ hybridization assays on urine cytology specimens
por: Chang, Sue, et al.
Publicado: (2015)

Submicroscopic interstitial deletion of chromosome 11q22.3 in a girl with mild mental retardation and facial dysmorphism: Case report
por: Krgovic, Danijela, et al.
Publicado: (2011)

Rare structural variants in the DOCK8 gene identified in a cohort of 439 patients with neurodevelopmental disorders
por: Krgovic, Danijela, et al.
Publicado: (2018)

A mosaic form of microphthalmia with linear skin defects
por: Prepeluh, Nina, et al.
Publicado: (2018)

An evaluation of SOX2 and hTERC gene amplifications as screening markers in oral and oropharyngeal squamous cell carcinomas
por: Kokalj Vokač, Nadja, et al.
Publicado: (2014)

A coalescence of two syndromes in a girl with terminal deletion and inverted duplication of chromosome 5
por: Krgovic, Danijela, et al.
Publicado: (2014)

Identification of genomic copy number variations associated with specific clinical features of head and neck cancer
por: Zagradišnik, Boris, et al.
Publicado: (2018)

TMPRSS2:ERG gene aberrations may provide insight into pT stage in prostate cancer
por: Krstanoski, Zoran, et al.
Publicado: (2016)

CNVs and Chromosomal Aneuploidy in Patients With Early-Onset Schizophrenia and Bipolar Disorder: Genotype-Phenotype Associations
por: Gregoric Kumperscak, Hojka, et al.
Publicado: (2021)

UroMark—a urinary biomarker assay for the detection of bladder cancer
por: Feber, Andrew, et al.
Publicado: (2017)

Xpert® bladder cancer detection as a diagnostic tool in upper urinary tract urothelial carcinoma: preliminary results
por: D’Elia, Carolina, et al.
Publicado: (2022)

Incidence and Distribution of UroSEEK Gene Panel in a Multi-institutional Cohort of Bladder Urothelial Carcinoma
por: Eich, Marie-Lisa, et al.
Publicado: (2019)

Urine and bladder washing cytology for detection of urothelial carcinoma: standard test with new possibilities
por: Flezar, Margareta Strojan
Publicado: (2010)

Assessment of Xpert Bladder Cancer Monitor test performance for the detection of recurrence during non-muscle invasive bladder cancer follow-up
por: Cancel-Tassin, G., et al.
Publicado: (2021)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

Prioritizing potential circRNA biomarkers for bladder cancer and bladder urothelial cancer based on an ensemble model
por: Su, Qiongli, et al.
Publicado: (2022)

Uro-Genital Tuberculosis: With Especial Consideration of Tuberculosis of the Bladder
por: Lewis, Bransford
Publicado: (1909)

Use of the Nuclear Matrix Protein 22 BladderChek Test for the Detection of Primary and Recurrent Urothelial Carcinoma
por: Xia, Chang-sheng, et al.
Publicado: (2020)

Urothelial carcinoma of the bladder with asynchronous metastases to both testes
por: Kiely, Gemma, et al.
Publicado: (2013)

Diagnostic Accuracy of Xpert Test in Tuberculosis Detection: A Systematic Review and Meta-analysis
por: Kaur, Ravdeep, et al.
Publicado: (2016)

Urovysion FISH Could Be Effective and Useful Method to Confirm the Identity of Cultured Circulating Tumor Cells from Bladder Cancer Patients
por: Kim, Tae-Jung, et al.
Publicado: (2019)

Primary Urothelial Bladder Cancer in a Young Patient: A Case Report and Review of the Literature
por: Alhubaishy, Bandar, et al.
Publicado: (2021)

Prognosis and immune infiltration analysis of endoplasmic reticulum stress-related genes in bladder urothelial carcinoma
por: Wang, Yaxuan, et al.
Publicado: (2022)

Sequence Variants in PSMB8/PSMB9 Immunoproteasome Genes and Risk of Urothelial Bladder Carcinoma
por: Elhawary, Nasser A, et al.
Publicado: (2023)

Nefro-Uro /
Publicado: (2018)

Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study)
por: Bersanelli, Melissa, et al.
Publicado: (2021)

Clinical value of M1 macrophage-related genes identification in bladder urothelial carcinoma and in vitro validation
por: Yu, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_440ol38fr6ucrlqk2s9mmjcolr